|
54 Companies |
|
104 Products |
|
104 Products |
|
62 Mechanisms of Action |
|
2 Trials |
|
669 News |
|
| «12345678910111213» |
- Premarin topical (equine conjugated estrogens) / Pfizer
New P4 trial: Effect of Preoperative Estrogen Treatment on Connective Tissues of the Pelvic Floor (clinicaltrials.gov) - Jan 27, 2013
P4, N=30, Completed, Sponsor: University of Texas Southwestern Medical Center
- Trial withdrawal: The Use of DHEA in Women With Premature Ovarian Failure (clinicaltrials.gov) - Jan 25, 2013
P0, N=0, Withdrawn, Sponsor: Virginia Center for Reproductive Medicine
Recruiting --> Withdrawn
- Enrollment change: The Use of DHEA in Women With Premature Ovarian Failure (clinicaltrials.gov) - Jan 25, 2013
P0, N=0, Withdrawn, Sponsor: Virginia Center for Reproductive Medicine
Recruiting --> Withdrawn N=25 --> 0
- leuprolide acetate for depot suspension / Generic mfg.
New P4 trial: Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist (clinicaltrials.gov) - Jan 24, 2013
P4, N=40, Recruiting, Sponsor: Malcolm G. Munro
- Enrollment change: Inofolic NRT and the Metabolic Syndrome (clinicaltrials.gov) - Jan 14, 2013
P=N/A, N=80, Completed, Sponsor: University of Messina
N=25 --> 0 N=120 --> 80
- Enrollment closed: Following Lipectomy to Understand Adipose Tissue Re-accumulation (clinicaltrials.gov) - Jan 14, 2013
P=N/A, N=80, Active, not recruiting, Sponsor: University of Colorado, Denver
N=120 --> 80 Recruiting --> Active, not recruiting
- Trial completion: Inofolic NRT and the Metabolic Syndrome (clinicaltrials.gov) - Jan 14, 2013
P=N/A, N=80, Completed, Sponsor: University of Messina
Recruiting --> Active, not recruiting Recruiting --> Completed
- ||||||| Vaginorm (dehydroepiandrosterone) / Endoceutics, Bayer
Trial completion: DHEA Against Vaginal Atrophy - Safety Study of 12 Months (clinicaltrials.gov) - Jan 12, 2013
P3, N=530, Completed, Sponsor: EndoCeutics Inc.
Recruiting --> Completed Active, not recruiting --> Completed
- ||| Trial completion: Angeliq rPMS: Angeliq Regulatory Post Marketing Surveillance (clinicaltrials.gov) - Jan 3, 2013
P=N/A, N=4078, Completed, Sponsor: Bayer
Active, not recruiting --> Completed Recruiting --> Completed
- Clinical: Calorie Restriction With Leucine Supplementation (clinicaltrials.gov) - Dec 26, 2012
P=N/A, N=75, Recruiting, Sponsor: Washington University School of Medicine
- Trial completion: Effect of Estrogen Therapy on Objective Sleep Quality in Postmenopausal Women (clinicaltrials.gov) - Dec 25, 2012
P3, N=40, Completed, Sponsor: Chulalongkorn University
Recruiting --> Completed Recruiting --> Completed
- | New P2 trial, Surgery: Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery (clinicaltrials.gov) - Dec 19, 2012
P2, N=82, Recruiting, Sponsor: Roswell Park Cancer Institute
- Enrollment open: Role of Oxytocin in Post-menopausal Osteoporosis: Evaluation on the Population of the OPUS Cohort (clinicaltrials.gov) - Dec 16, 2012
P=N/A, N=1000, Recruiting, Sponsor: Centre Hospitalier Universitaire de Nice
Recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment change, HEOR: Impact of Treatment Induced Premature Menopause on Quality of Life (clinicaltrials.gov) - Dec 11, 2012
P=N/A, N=97, Completed, Sponsor: Stanford University
Not yet recruiting --> Recruiting N=80 --> 97
- Trial completion, HEOR: Impact of Treatment Induced Premature Menopause on Quality of Life (clinicaltrials.gov) - Dec 11, 2012
P=N/A, N=97, Completed, Sponsor: Stanford University
N=80 --> 97 Active, not recruiting --> Completed
- Clinical: Anthropometric, Metabolic, Cardiovascular and Symptomatic Profile in Postmenopausal Women (clinicaltrials.gov) - Dec 5, 2012
P=N/A, N=45, Completed, Sponsor: University of Sao Paulo
- || New P3 trial: Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women (clinicaltrials.gov) - Dec 3, 2012
P3, N=340, Completed, Sponsor: Institute for Atherosclerosis Research, Russia
- | sapitinib (AZD8931) / AstraZeneca
Trial termination, Combination therapy, Metastases: MINT: Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer (clinicaltrials.gov) - Nov 15, 2012
P2, N=482, Terminated, Sponsor: AstraZeneca
Active, not recruiting --> Completed Active, not recruiting --> Terminated; Futility
- Enrollment closed: Ovarian Follicle Function in Patients With Primary Ovarian Failure (clinicaltrials.gov) - Nov 14, 2012
P=N/A, N=1134, Active, not recruiting, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Active, not recruiting --> Terminated; Futility Recruiting --> Active, not recruiting
- | Trial termination: EMPOWER: Surveillance Study of Women Taking Intrinsa (clinicaltrials.gov) - Oct 31, 2012
P4, N=328, Terminated, Sponsor: Center for Epidemiology and Health Research, Germany
Recruiting --> Active, not recruiting Recruiting --> Terminated; The marketing authorization for Intrinsa was withdrawn.
- Enrollment change: EMPOWER: Surveillance Study of Women Taking Intrinsa (clinicaltrials.gov) - Oct 31, 2012
P4, N=328, Terminated, Sponsor: Center for Epidemiology and Health Research, Germany
Recruiting --> Terminated; The marketing authorization for Intrinsa was withdrawn. N=10800 --> 328
- || goserelin acetate / Generic mfg., tamoxifen / Generic mfg.
New P3 trial: Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer (clinicaltrials.gov) - Oct 22, 2012
P3, N=220, Recruiting, Sponsor: Fudan University
- | Alora (estradiol) / AbbVie
Enrollment change: A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women (clinicaltrials.gov) - Oct 10, 2012
P4, N=27, Completed, Sponsor: Watson Pharmaceuticals
N=10800 --> 328 N=35 --> 27
- ||||| norethindrone / Generic mfg.
New P4 trial: Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle (clinicaltrials.gov) - Oct 10, 2012
P4, N=191, Completed, Sponsor: Novo Nordisk
- |||| leuprolide acetate for depot suspension / Generic mfg.
Trial completion: GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients (clinicaltrials.gov) - Oct 4, 2012
P2, N=60, Completed, Sponsor: M.D. Anderson Cancer Center
N=35 --> 27 Active, not recruiting --> Completed
- Trial completion: Mindfulness Based Stress Reduction for Hot Flashes (clinicaltrials.gov) - Oct 2, 2012
P1, N=110, Completed, Sponsor: University of Massachusetts, Worcester
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| New P3 trial: Monalisa: Efficacy and Safety of Passiflora Incarnata and Isoflavona Combination in the Treatment of Climacteric Symptoms (clinicaltrials.gov) - Sep 26, 2012
P3, N=144, Not yet recruiting, Sponsor: Ache Laboratorios Farmaceuticos S.A.
- ||| Premarin topical (equine conjugated estrogens) / Pfizer, Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Trial completion, Combination therapy: DRIVE: Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms (clinicaltrials.gov) - Sep 20, 2012
P=N/A, N=58, Completed, Sponsor: University of Alabama at Birmingham
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change: Sex, Aging and Antiretroviral Pharmacokinetics (clinicaltrials.gov) - Sep 17, 2012
P=N/A, N=11, Completed, Sponsor: Kristine Patterson, MD
Active, not recruiting --> Completed N=42 --> 11
- Trial completion: Sex, Aging and Antiretroviral Pharmacokinetics (clinicaltrials.gov) - Sep 17, 2012
P=N/A, N=11, Completed, Sponsor: Kristine Patterson, MD
N=42 --> 11 Recruiting --> Completed
- | Enrollment change: Effect of Genistein in Women With Metabolic Syndrome (clinicaltrials.gov) - Sep 12, 2012
P2/3, N=120, Completed, Sponsor: University of Messina
Recruiting --> Completed N=180 --> 120
- | Trial completion: Effect of Genistein in Women With Metabolic Syndrome (clinicaltrials.gov) - Sep 12, 2012
P2/3, N=120, Completed, Sponsor: University of Messina
N=180 --> 120 Recruiting --> Completed
- Livial (tibolone) / Merck (MSD)
Clinical: Vascular Effect of Tibolone Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery (clinicaltrials.gov) - Sep 4, 2012
P=N/A, N=60, Recruiting, Sponsor: Federal University of Minas Gerais
- vildagliptin / Generic mfg., gliclazide / Generic mfg.
New P4 trial: BoneGlyc: Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability (clinicaltrials.gov) - Sep 4, 2012
P4, N=38, Recruiting, Sponsor: Centro de Diabetes Curitiba Ltda
- Livial (tibolone) / Organon
Enrollment open: Vascular Effect of Tibolone in the Brachial Artery (clinicaltrials.gov) - Sep 4, 2012
P=N/A, N=60, Recruiting, Sponsor: Selmo Geber
Recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment closed: Hormones and Cognition in the Menopausal Transition (clinicaltrials.gov) - Sep 3, 2012
P=N/A, N=90, Active, not recruiting, Sponsor: University of Rochester
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Zavicefta (ceftazidime/avibactam) / Pfizer, AbbVie
Enrollment change: Study to Assess the Concentration of Avibactam and Ceftazidime in Epithelial Lining Fluid and Plasma (clinicaltrials.gov) - Aug 15, 2012
P1, N=45, Completed, Sponsor: AstraZeneca
Recruiting --> Active, not recruiting N=63 --> 45
- | ibandronate sodium hydrate / Generic mfg.
Enrollment change, Compliance: A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Na (clinicaltrials.gov) - Aug 14, 2012
P3, N=41, Active, not recruiting, Sponsor: Hoffmann-La Roche
N=63 --> 45 N=60 --> 41
- | ibandronate sodium hydrate / Generic mfg.
Enrollment closed, Compliance: A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Na (clinicaltrials.gov) - Aug 14, 2012
P3, N=41, Active, not recruiting, Sponsor: Hoffmann-La Roche
N=60 --> 41 Recruiting --> Active, not recruiting
- | Zavicefta (ceftazidime/avibactam) / Pfizer, AbbVie
Trial completion: Study to Assess the Concentration of Avibactam and Ceftazidime in Epithelial Lining Fluid and Plasma (clinicaltrials.gov) - Aug 13, 2012
P1, N=45, Completed, Sponsor: AstraZeneca
Recruiting --> Active, not recruiting Recruiting --> Completed
- || New P2/3 trial: Effects of Genistein in Postmenopausal Women With Metabolic Syndrome (clinicaltrials.gov) - Aug 12, 2012
P2/3, N=120, Completed, Sponsor: University of Messina
- fluoxetine / Generic mfg.
Enrollment open: HOMDEP-MENOP: Homeopathic Treatment for Depression in Peri- and Postmenopausal Women (clinicaltrials.gov) - Aug 12, 2012
P2, N=189, Recruiting, Sponsor: Hospital Juarez de Mexico
Recruiting --> Completed Active, not recruiting --> Recruiting
- letrozole / Generic mfg., erlotinib / Generic mfg.
Trial termination, Metastases: Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer. (clinicaltrials.gov) - Aug 2, 2012
P2, N=48, Terminated, Sponsor: Vanderbilt-Ingram Cancer Center
Active, not recruiting --> Recruiting Active, not recruiting --> Terminated; low accrual
- Trial termination: DHEAFert2: Dehydroepiandrosterone (DHEA) Treatment and Premature Ovarian Failure (POF) (clinicaltrials.gov) - Aug 1, 2012
P2/3, N=5, Terminated, Sponsor: David H. Barad
Active, not recruiting --> Terminated; low accrual Recruiting --> Terminated; Lack of recruitment.
- Enrollment change: DHEAFert2: Dehydroepiandrosterone (DHEA) Treatment and Premature Ovarian Failure (POF) (clinicaltrials.gov) - Aug 1, 2012
P2/3, N=5, Terminated, Sponsor: David H. Barad
Recruiting --> Terminated; Lack of recruitment. N=240 --> 5
- Clinical: MedSD: Mediterranean Diet for Post-menopausal Women: Effects on Bone Turnover (clinicaltrials.gov) - Jul 26, 2012
P=N/A, N=20, Recruiting, Sponsor: University of Connecticut Health Center
- | Trial completion: A Study to Investigate the Effects of Food and Morning Versus Evening on Single and Multiple Doses of ONO-5334 in Healthy Post Menopausal Women (clinicaltrials.gov) - Jul 23, 2012
P1/2, N=25, Completed, Sponsor: Ono Pharmaceutical Co. Ltd
N=240 --> 5 Active, not recruiting --> Completed
- |||| desvenlafaxine extended release / Generic mfg.
Enrollment open: Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients (clinicaltrials.gov) - Jul 11, 2012
P4, N=3000, Recruiting, Sponsor: Pfizer
Active, not recruiting --> Completed Active, not recruiting --> Recruiting
- || Enrollment change: JULINA-CLIMA: Julina Post-marketing Surveillance for Climacteric Symptoms in Japan (clinicaltrials.gov) - Jul 9, 2012
P=N/A, N=506, Completed, Sponsor: Bayer
Active, not recruiting --> Recruiting N=400 --> 506
- ||| Trial completion: JULINA-CLIMA: Julina Post-marketing Surveillance for Climacteric Symptoms in Japan (clinicaltrials.gov) - Jul 9, 2012
P=N/A, N=506, Completed, Sponsor: Bayer
N=400 --> 506 Recruiting --> Completed